476 related articles for article (PubMed ID: 15613403)
21. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis.
Gao Y; Chen M; Ye H; Yu F; Guo XH; Zhao MH
Rheumatology (Oxford); 2008 Oct; 47(10):1515-20. PubMed ID: 18676500
[TBL] [Abstract][Full Text] [Related]
22. Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis.
Neumann I; Kain R; Regele H; Soleiman A; Kandutsch S; Meisl FT
Nephrol Dial Transplant; 2005 Jan; 20(1):96-104. PubMed ID: 15546891
[TBL] [Abstract][Full Text] [Related]
23. Clinical and pathological features of renal involvement in propylthiouracil-associated ANCA-positive vasculitis.
Yu F; Chen M; Gao Y; Wang SX; Zou WZ; Zhao MH; Wang HY
Am J Kidney Dis; 2007 May; 49(5):607-14. PubMed ID: 17472842
[TBL] [Abstract][Full Text] [Related]
24. Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study.
Haubitz M; Schellong S; Göbel U; Schurek HJ; Schaumann D; Koch KM; Brunkhorst R
Arthritis Rheum; 1998 Oct; 41(10):1835-44. PubMed ID: 9778225
[TBL] [Abstract][Full Text] [Related]
25. ANCA-associated necrotizing/granulomatous glomerulonephritis in an elderly patient; importance of the renal biopsy.
Isaac J; Clayton F; Rohr R; Herrera GA
Rev Invest Clin; 2001; 53(1):88-90. PubMed ID: 11332056
[TBL] [Abstract][Full Text] [Related]
26. Adverse effects of therapy for ANCA-associated vasculitis.
Turnbull J; Harper L
Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):391-401. PubMed ID: 19508946
[TBL] [Abstract][Full Text] [Related]
27. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR
Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
[TBL] [Abstract][Full Text] [Related]
28. Smoking habits in patients diagnosed with ANCA associated small vessel vasculitis.
Haubitz M; Woywodt A; de Groot K; Haller H; Goebel U
Ann Rheum Dis; 2005 Oct; 64(10):1500-2. PubMed ID: 16162902
[TBL] [Abstract][Full Text] [Related]
29. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis.
Keogh KA; Wylam ME; Stone JH; Specks U
Arthritis Rheum; 2005 Jan; 52(1):262-8. PubMed ID: 15641078
[TBL] [Abstract][Full Text] [Related]
30. Renal vasculitis: increasingly a disease of the elderly?
Satchell SC; Nicholls AJ; D'Souza RJ; Beaman M
Nephron Clin Pract; 2004; 97(4):c142-6. PubMed ID: 15331937
[TBL] [Abstract][Full Text] [Related]
31. Renal disease associated with circulating antineutrophil cytoplasm activity.
Garrett PJ; Dewhurst AG; Morgan LS; Mason JC; Dathan JR
Q J Med; 1992 Oct; 85(306):731-49. PubMed ID: 1287705
[TBL] [Abstract][Full Text] [Related]
32. Opportunistic infections are preceded by a rapid fall in antineutrophil cytoplasmic antibody (ANCA) titer in patients with ANCA associated vasculitis.
Palsson R; Choi HK; Niles JL
J Rheumatol; 2002 Mar; 29(3):505-10. PubMed ID: 11908563
[TBL] [Abstract][Full Text] [Related]
33. [Clinical features and outcomes of hyperthyroidism patients positive in propylthiouracil-induced antineutrophil cytoplasmic antibody].
Ye H; Gao Y; Guo XH; Zhao MH
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3323-7. PubMed ID: 16409836
[TBL] [Abstract][Full Text] [Related]
34. Clinical features and outcome of pediatric Wegener's granulomatosis.
Akikusa JD; Schneider R; Harvey EA; Hebert D; Thorner PS; Laxer RM; Silverman ED
Arthritis Rheum; 2007 Jun; 57(5):837-44. PubMed ID: 17530684
[TBL] [Abstract][Full Text] [Related]
35. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis.
Jayne DR; Gaskin G; Rasmussen N; Abramowicz D; Ferrario F; Guillevin L; Mirapeix E; Savage CO; Sinico RA; Stegeman CA; Westman KW; van der Woude FJ; de Lind van Wijngaarden RA; Pusey CD;
J Am Soc Nephrol; 2007 Jul; 18(7):2180-8. PubMed ID: 17582159
[TBL] [Abstract][Full Text] [Related]
36. [Clinical feature analysis of 190 patients with anti-neutrophil cytoplasmic antibodies associated vasculitis].
Chen J; Niu YH; Li GL; Wang GF; Zhao MH
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(36):2548-51. PubMed ID: 20137616
[TBL] [Abstract][Full Text] [Related]
37. Outcome analysis of patients with vasculitis associated with antineutrophil cytoplasmic antibodies.
Brijker F; Magee CC; Tervaert JW; O'Neill S; Walshe JJ
Clin Nephrol; 1999 Dec; 52(6):344-51. PubMed ID: 10604641
[TBL] [Abstract][Full Text] [Related]
38. [Anti-neutrophil cytoplasmic antibody-associated vasculitis. Clinical aspects and treatment].
Paolini MV; Ruffino JP; Fernández Romero DS
Medicina (B Aires); 2013; 73(2):119-26. PubMed ID: 23570759
[TBL] [Abstract][Full Text] [Related]
39. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
Tervaert JW; Stegeman CA
Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2265-7. PubMed ID: 14655291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
